×
Back to Agenda
Session 1: ANDA First Cycle Approvals
Session Chair(s)
Sarah Ibrahim, PharmD, PhD
Associate Director for Stakeholder and Global Engagement, Office of Generic Drug
FDA, United States
Have an account?